Prosecution Insights
Last updated: October 04, 2026

Nuclein LLC

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Nuclein LLC is engaged in the Chemistry & Materials technology area, where it currently manages 3 pending office actions. These 3 pending office actions are distributed across 3 distinct examiners and 3 distinct art units. This distribution indicates a diverse prosecution landscape, with each pending matter being reviewed by a different individual.

The busiest examiner for this portfolio is CROW, ROBERT THOMAS, who is responsible for 1 pending office action. Since there are 3 pending office actions in total, the workload is split among the 3 distinct examiners. This level of dispersion across 3 distinct art units suggests that the company's filings cover a broad range of technical applications within the Chemistry & Materials field.

For practitioners, managing 3 pending office actions across 3 distinct examiners requires a multifaceted strategy. Each examiner may have different procedural preferences and interpretations of the prior art. The presence of CROW, ROBERT THOMAS as one of the examiners highlights the need for tailored responses that address the specific standards of each distinct art unit involved in the company's current prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
1
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)3 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CROW, ROBERT THOMAS 1 41.7% +32.7%
NGUYEN, HENRY H 1 63.7% +37.2%
KRCHA, MATTHEW D 1 64.7% +35.3%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18038181 DIRECT LYSIS APPARATUS AND METHODS FOR MOLECULAR DIAGNOSTICS NGUYEN, HENRY H 82d
18558061 ANALYTE DETECTION CARTRIDGE AND METHODS OF USE THEREOF CROW, ROBERT THOMAS —
18037282 APPARATUS AND METHODS FOR MOLECULAR DIAGNOSTICS KRCHA, MATTHEW D —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18038181 DIRECT LYSIS APPARATUS AND METHODS FOR MOLECULAR DIAGNOSTICS NGUYEN, HENRY H 82d
18558061 ANALYTE DETECTION CARTRIDGE AND METHODS OF USE THEREOF CROW, ROBERT THOMAS —
18037282 APPARATUS AND METHODS FOR MOLECULAR DIAGNOSTICS KRCHA, MATTHEW D —

Top Art Units

Art UnitApps
1683 1
1758 1
1796 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18558061 ANALYTE DETECTION CARTRIDGE AND METHODS OF USE THEREOF CROW, ROBERT THOMAS 1683 §102§103§112 Non-Final OA — Pending Oct 30, 2023
18038181 DIRECT LYSIS APPARATUS AND METHODS FOR MOLECULAR DIAGNOSTICS NGUYEN, HENRY H 1758 §102§103 Final Rejection 82d Pending May 22, 2023
18037282 APPARATUS AND METHODS FOR MOLECULAR DIAGNOSTICS KRCHA, MATTHEW D 1796 §103§112 Final Rejection — Pending May 16, 2023

Managing Nuclein LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month